Generic name:coagulation factor ix recombinant, glycopegylated (intravenous route) [ koh-a-gyoo-LAY-shun-FAK-tor-NINE-ree-KOM-bin-ant, glye-koe-PEG-il-ay-ted ]
Drug class:Miscellaneous coagulation modifiers
Medically reviewed by Drugs.com. Last updated on May 5, 2022.
Commonly used brand name(s)
In the U.S.
- Rebinyn
Available Dosage Forms:
- Powder for Solution
Therapeutic Class: Antihemophilic Agent
Uses for Rebinyn
Coagulation factor IX (recombinant), glycoPEGylated injection is used to control bleeding episodes and prevent bleeding during surgery in patients with hemophilia B (congenital Factor IX deficiency).
Factor IX is a protein that is produced naturally in the body. This medicine is a man-made protein produced to replicate the naturally occurring factor IX in the body. It is used to stop bleeding by helping the blood to clot in patients with hemophilia B.
This medicine is to be given only by or under the supervision of your doctor or other health care professional.
Before using Rebinyn
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of coagulation factor IX (recombinant), glycoPEGylated injection in children.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of coagulation factor IX (recombinant), glycoPEGylated inje...
